II
BMY icon

Impact Investors’s Bristol-Myers Squibb BMY Stock Holding History

Impact Investors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$448K Buy
+7,386
New +$431K 0.31% 50

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Impact Investors's BMY Position: Q1 2026 in Review

Impact Investors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 7,386 shares worth $448K. The stake represents 0.31% of the portfolio and ranks #50 among its holdings.

2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Impact Investors held 7,386 shares of Bristol-Myers Squibb worth $448K as of Q1 2026.
  • Bristol-Myers Squibb was a new Impact Investors position in Q1 2026.
  • Bristol-Myers Squibb made up 0.31% of Impact Investors's portfolio in Q1 2026, its #50 holding.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Impact Investors's 13F filing for Q1 2026, filed 29 Apr 2026.